A daganat-terápia alapjai Diagnosis –Histopathology –Tumor markers Cell surface markers (CD20, CD34…) Genetic markers (BRCA-1,Philadelphia chromosome)

Slides:



Advertisements
Similar presentations
Dr. Amal S. Ahmed Ass Prof.Clinical Pathology Suez Canal University
Advertisements

Neoplasms.
Oncology Assessment and Management of Patients With Cancer Breast Prepared by Dr. Iman Abdullah.
Cancer Dr. Raid Jastania. Cancer In the US: 1.3 million new cancer cases in 2002 >500,000 death of cancer Increase cancer death in men due to lung cancer.
TREATMENTS Surgical Oncology Chemotherapy Radiation Therapy Bone Marrow Transplant Complementary Medicine Psychotherapy.
Maša Radeljak Mentor: A. Žmegač Horvat
Dr.Huda abd-alkarim. Assistant prof.& consultant oncologist.
Chapter 19 Cancer and the Immune System Dr. Capers.
Basics of Pediatric Oncology Margret E. Merino, MD Pediatric Hematology/Oncology WRAMC.
Children Understanding Cancer Roswell Park Cancer Institute Grades K-4.
Cancer Card Game Answers etc.
By Taylor, Lanny, and Alex. What is it?  Leukemia is an abnormal rise in the number of white blood cells. The white blood cells crowd out other blood.
Eleni Galani Medical Oncologist
HOW TO CONTROL CANCER Putting Science into Practice.
Neoplasms.
Neoplasia I Walter C. Bell, M.D..
Section 2 Interventions  Nutrition  Activity  Breathing  Fatigue  Comfort.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 100 Basic Principles of Cancer Chemotherapy.
New Developments in Cancer Treatment Dulcinea Quintana, MD.
LUNG CANCER Dr.Mohammadzadeh. Lung cancer is the leading cancer killer in the United States. Every year, it accounts for 30% of all cancer deaths— more.
 Identify different options of cancer therapy.  Most cancers are treated with a combination of approaches.
Chapter 21 Cancer and the Immune System Dr. Capers
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Regulating the Cell Cycle Biology 392 Chapter 10-3.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Tumormarkers.
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
Breast Cancer By: Christen Scott.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.
Phase I Study of PLX4032: Proof of Concept for V600E BRAF Mutation as a Therapeutic Target in Human Cancer Flaherty K et al. American Society of Clinical.
Cancer Over a hundred diseases are called cancer..
CANCER CONTROL NHPA’s. What is it? Cancer is a term to describe a diverse group of diseases in which some of the cells in body become defective. The following.
Associated Web sites CustomizableMaps The Atlas On-Line.
Linda S. Williams / Paula D. Hopper Copyright © F.A. Davis Company Understanding Medical Surgical Nursing, 4th Edition Chapter 11 Nursing Care of.
Cancer of the blood: Leukemia
Cancer Basics EQ: What does cancer have to do with the cell cycle?
Regulating The Cell Cycle. Warm Up – The Cell Cycle The cell spends 80% of the time in _______________ and 20% of the time in ________________ What are.
Neuroblastoma.
A Phase 2 Study with a Daily Regimen of the Oral mTOR Inhibitor RAD001 (Everolimus) in Patients with Metastatic Clear Cell Renal Cell Cancer Amato RJ et.
Cancer Chemotherapy Dr.Azarm.  The goal of cancer treatment is eradication of cancer  If not possible shifts to palliation,amelioration and preservation.
TREATMENT APPROACHES OF CANCER Orhan Onder Eren, MD Yeditepe University Hospital Department of Medical Oncology.
Cancer – a substance that causes cancer – a substance that causes cancer –Examples include tobacco smoke, ultraviolet rays, and asbestos Carcinogen.
Neoplasia 7 Dr. Hiba Wazeer Al Zou’bi. Clinical aspects of neoplasia Both malignant and benign tumors may cause problems because of (1) location and impingement.
Cancer: Uncontrolled Cell Division Biology 12. Some Stats from WHO: Cancer is a leading cause of death group worldwide and accounted for 7.4 million deaths.
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
Cancer 101 William E. Janssen, Ph.D. Director, Cell Therapies Facility Moffitt Cancer Center Cindy Eller VP for Development Roswell Park Cancer Institute.
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer Slideset on: Piccart-Gebhart M, Procter M, Leyland- Jones B, et al. Trastuzumab.
YOUR CANCER TREATMENT: WHAT TO EXPECT FROM THE LATEST ADVANCEMENTS MIRIAM J. ATKINS, M.D.
CANCER.
Treatment for Cancer. Surgery Treatment and prognosis depend on severity and spread of the cancer Treatment and prognosis depend on severity and spread.
CANCER Tomsk CONTENTS INTRODUCTION THE MOST COMMON TYPES OF CANCER SKIN CANCER LUNG CANCER KIDNEY CANCER BREAST CANCER THYROID CANCER TREATMENT.
Cancer Excessive Division Invading Mouth Cancer Oral cancer Treatments: surgery and can be life threatening.
Bijoy Telivala, MD Advances in Immunotherapy Bijoy Telivala, MD
Omega Best Cancer Hospital - India
Bronchial Carcinoma Part 2
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
Oncology Assessment and Management of Patients With Cancer Breast
Slide set on: McCarthy PL, Owzar K, Hofmeister CC, et al
QUESTIONS OF LUNG CANCER
Introduction to medical oncology
Maria Belgun, L.Dumitriu, A.Goldstein, Mariana Purice, F.Alexiu
chimeric antigen receptor T-cell therapy for ALL
Basic Principles of Cancer Chemotherapy
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Cancer and Sarcoma Vocabulary Lesson
Carcinomas of lung By: Shefaa’ Qa’qa’.
Cancer.
Clinical responses in patients.
Cancer: Uncontrolled Cell Division
Cancer Treatment.
Presentation transcript:

a daganat-terápia alapjai Diagnosis –Histopathology –Tumor markers Cell surface markers (CD20, CD34…) Genetic markers (BRCA-1,Philadelphia chromosome) Tumor markers in the blood – α-FP (testis, HCC), –β-HCG (testis, trophoblastic neoplasia –PSA –CEA (colorectal, breast, lung), –CEA125(ovary), –CA199(pancreas), – thyroglobulin (thyroid) –Lactic dehydrogenase, LDH.

Staging –TMN staging: (for solid tumors) T: tumor size N: node involvement M: metastases Ex: T 2 N 1 M 0 a daganat-terápia alapjai

Modalities of Treatment –Surgery –Radiation –Chemotherapy a daganat-terápia alapjai

Immunotherapy (melanoma, Bladder cancer, renal cell carcinoma) BCG Vsaccine (local regional bladder cancer) Monoclonal antibody –Trastuzumab –rituximab Hormonal therapy (breast cancer, prostate cancer) Drugs inducing differentiation –all-tans retinoic acid (ATRA) Hematopoietic stem cell transplantation a daganat-terápia alapjai

Criteria for Response –Cure: patient is entirely free of disease and has the same life expectancy. –Complete response (CR): complete disappearance of all cancer and no evidence of new disease for at least 1 month. –Partial response (PR) : 50% or greater decrease in the tumor size or other disease markers, and no evidence or any new disease for at least 1 month. –Stable disease: tumor size neither grows nor shrinks significantly. –Progression of disease: 25% increase in the tumor size or the development of and new lesions while receiving treatment. a daganat-terápia alapjai

Management of treatment-related toxicity –Infections –Hematological reactions –Nausea and vomiting –Oral complications –Pulmonary complications –Cardiac toxicities –Gonadal dysfunction –Second cancers –Neurotoxicity –Nephrotoxicity –Hepatotoxiity a daganat-terápia alapjai

Paraneoplastic syndrome Chronic adrenocortical insufficiency –Adrenal, lymphoma Dermatomyositis and polymyositis –Lung, stomach, ovary Hypercalcemia: –Lung, breast, prostate DIC : Acute promyelocytic leukemia SIADH: Lung, esp. SCLC Thrombophlebitis: –lung, breast, ovary, Prostate

Summary Cancer is not a single disease entity. Cancer biology is the most important aspect in treating or preventing cancers Chemotherapy pharmacy service or oncology pharmacy service Know the general concepts of cancers, focus on the drug-related problems.